SANUWAVE Health Inc(US:SNWV)2025-05-26 19:05Financial Performance - Revenue for Q4 2024 reached $10.3 million, a 47% increase compared to $7.0 million in Q4 2023 [15] - Gross profit for Q4 2024 was $8.0 million, a 67% increase compared to $4.8 million in Q4 2023 [15] - Gross margin improved to 77.9% in Q4 2024, up 873 basis points from 69.1% in Q4 2023 [15] - Operating income for Q4 2024 was $2.5 million, a 150% increase compared to $1.0 million in Q4 2023 [15] - Adjusted EBITDA for Q4 2024 was $3.655 million, compared to $0.664 million in Q4 2023 [16] UltraMIST System - UltraMIST system saw continuous revenue growth with strong year-over-year growth throughout 2024 [18] - The company had 1,047 UltraMIST systems in the field at the end of Q4 2024 [20] - 135 UltraMIST systems were sold in Q4 2024, compared to 79 in Q4 2023 and 124 in Q3 2024 [20] Revenue Guidance - The company projects Q1 2025 revenue growth of 45-55% compared to Q1 2024 revenue of $5.79 million [23] - The company forecasts FY 2025 revenue of $48-50 million, representing a 47-53% increase compared to FY 2024 revenue of $32.6 million [23]